Skip to main content
OpenTrials
Completed

NCT Number: NCT04623762

Yoga On Dyspnea, Sleep And Fatıgue In Chronıc Respıratory Dıseases

Although there are a limited number of studies in the literature investigating the effect of yoga on dyspnea, quality of life and respiratory functions of chronic respiratory patients There is no study examining the effect of yoga on sleep and fatigue of chronic respiratory patients. Therefore, this study was conducted to determine the effect of yoga on dyspnea, sleep, and fatigue applied to chronic respiratory patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Respiratory Disease

Age range

18 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Fırat university, Erzurum, Center, Turkey (Türkiye)

Loading trial locations.

About this study

Chronic respiratory diseases (CSFD) are chronic diseases of the airways and other structures of the lung. Two of the most common of these diseases are asthma and chronic obstructive pulmonary disease. Asthma and chronic obstructive pulmonary disease (COPD); mortality, morbidity and prevalence of chronic respiratory diseases are increasingly increasing across countries. COPD; It has been defined as a common, preventable and treatable disease characterized by permanent airflow restriction, which is associated with the increased chronic inflammatory response of the airways and lungs to harmful gases and particles Every year, 3 million people die of COPD in the world and this rate constitutes 6% of all deaths If it is asthma; It is defined as a heterogeneous disease characterized by chronic airway inflammation associated with airway hyperresponsiveness to direct or indirect stimuli. Asthma is seen at a rate of 1-18% in the whole world population

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Between the ages of 18-55 and diagnosed with asthma and COPD for at least six months,
  • Do not have any disease that causes insomnia and do not use sleeping pills
  • Has the ability to use the internet actively, download the ZOOM program to the phone or computer and participate in the application.

Have not participated in a similar regular exercise program in the last 6 months,

  • Do not have any respiratory system disease other than asthma and COPDY,
  • Not in exacerbation period,
  • Do not have a physical illness or cognitive deficiency and a psychiatric disease that prevents understanding of the education given,
  • Patients who were literate and volunteered to participate in the study were included in the study.

Exclusion criteria

  • In the period of exacerbation Have participated in a similar regular exercise program in the last 6 months, Those who cannot download the ZOOM program and participate in the application

Treatment and study plan

yoga

Other

yoga application

Primary outcomes

  1. Chronic Obstructive Pulmonary Disease and Asthma Fatigue Scale

    Time frame: Change from Baseline Fatigue at 2 months

    Revicki et al. (2010) to determine the effect of COPD and asthma on fatigue. Cronbach's alpha value of the scale was found to be 0.95. The scale, which consists of 12 items, is a five-point Likert type, and the minimum total score that can be obtained from the scale is 12 and the maximum total score is 60. The higher the score obtained from the scale indicates that the fatigue level of the person is high. Turkey on the scale of the Turkish validity and reliability study of Arslan and by Öztunç (2013) was determined to be conducted and Cronbach's alpha values for the reliability coefficient of 0.92.

Secondary outcomes

  1. Asthma and COPD Sleep Scale (CASIS)

    Time frame: Change from Baseline Sleep at 2 months

    It was developed by Pokrzywinski et al. (2009) to reveal the effect of asthma and COPD disease on sleep. The Cronbach Alpha Coefficient of the scale was found to be 0.90. The Turkish validity and reliability study of the scale was conducted by Ayhan and Kıyak (2011) and the cronbach alpha coefficient was determined as 0.87. The items of the questions in the scale consisting of 7 questions in total are likert in the form of never, rarely, sometimes, often, and very often.

Other outcomes

  1. Medical Research Board Dyspnea Scale (MRC):

    Time frame: Change from Baseline MRC at 2 months

    t is a five-item scale developed by the British Medical Research Board for the evaluation of dyspnea. While applying the Medical Research Council Dyspnea Scale, patients are asked to indicate the activity level that causes dyspnea. The patient chooses the most appropriate level that defines the respiratory distress by reading the options on the scale. The options are graded from 0 to 4; 0 points, no dyspnea; 1 point of mild dyspnea (respiratory distress when moving fast on a flat surface and climbing slightly uphill); 2 points of moderate dyspnea (walk slower than peers when walking on a flat surface, pausing to breathe); 3 points are scored as severe dyspnea (stopping to breathe after walking for 100 meters or a few minutes) and 4 points as very severe dyspnea (breathlessness while wearing clothes, taking off or going to the toilet while doing daily work at home).

  2. Pulmonary Functions Monitoring Form

    Time frame: Change from Baseline Pulmonary Functions at 2 months

    Pulmonary function tests are evaluated with the spirometer to determine the degree of airway limitation and whether it is reversible and to diagnose asthma. Forced vital capacity (FVC), forced expiratory volume in one second (FEV1), highest expiratory flow rate (PEF) and FEV1 / FVC measurements were evaluated to evaluate its restriction.

Sponsors and collaborators

Lead sponsor

Ataturk University

Other

Registry information

Official study title

Effect Of Yoga On Dyspnea, Sleep And Fatıgue In Chronıc Respıratory Dıseases

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Nov 10, 2020
Registry last updated
Nov 10, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.